These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 8735145)
21. Heterozygosity for the factor V Leiden (G1691A) mutation predisposes renal transplant recipients to thrombotic complications and graft loss. Wüthrich RP; Cicvara-Muzar S; Booy C; Maly FE Transplantation; 2001 Aug; 72(3):549-50. PubMed ID: 11502996 [TBL] [Abstract][Full Text] [Related]
22. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis. Dahlbäck B Thromb Haemost; 1995 Jul; 74(1):139-48. PubMed ID: 8578447 [TBL] [Abstract][Full Text] [Related]
23. Heterozygosity for factor V Leiden in a haemodialysis patient with recurrent shunt thrombosis. Bremer C; Schaefer RM Nephrol Dial Transplant; 1997 Aug; 12(8):1775-6. PubMed ID: 9269682 [No Abstract] [Full Text] [Related]
24. Factor V antigen levels in APC resistance, in factor V deficiency and in combined APC resistance and factor V deficiency (pseudohomozygosis for APC resistance). Girolami A; Simioni P; Venturelli U; Girolami B; Zanon E Blood Coagul Fibrinolysis; 1997 Jun; 8(4):245-8. PubMed ID: 9199822 [TBL] [Abstract][Full Text] [Related]
25. Coexistence of antithrombin deficiency, factor V Leiden and hyperhomocysteinemia in a thrombotic family. Gemmati D; Serino ML; Moratelli S; Mari R; Ballerini G; Scapoli GL Blood Coagul Fibrinolysis; 1998 Mar; 9(2):173-6. PubMed ID: 9622215 [TBL] [Abstract][Full Text] [Related]
26. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives. Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134 [TBL] [Abstract][Full Text] [Related]
27. Thrombosis involving the major veins with heterozygote factor V Leiden mutation as the only risk factor. Tokgözoğlu SL; Açil T; Haznedaroğlu IC; Aytemir K; Batur MK Clin Appl Thromb Hemost; 1999 Jul; 5(3):187-9. PubMed ID: 10726007 [TBL] [Abstract][Full Text] [Related]
28. Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis. Brenner B; Zivelin A; Lanir N; Greengard JS; Griffin JH; Seligsohn U Blood; 1996 Aug; 88(3):877-80. PubMed ID: 8704244 [TBL] [Abstract][Full Text] [Related]
29. Comparison of thrombotic risk between 85 homozygotes and 481 heterozygotes carriers of the factor V Leiden mutation: retrospective analysis from the Procare Study. Procare Group Blood Coagul Fibrinolysis; 2000 Sep; 11(6):511-8. PubMed ID: 10997790 [TBL] [Abstract][Full Text] [Related]
30. Discrimination between normal wildtype and carriers of coagulation factor V Leiden mutation by the activated protein C resistance test in the presence of factor V deficient plasma. Reuner KH; Litfin F; Patscheke H Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):41-5. PubMed ID: 9156566 [TBL] [Abstract][Full Text] [Related]
31. Factor V Leiden: an overview. Shaw DM Clin Lab Sci; 2006; 19(4):218-21. PubMed ID: 17181126 [TBL] [Abstract][Full Text] [Related]
32. Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study. Perez Botero J; Ormsby WD; Ashrani AA; McBane RD; Wysokinski WE; Patnaik MM; Lewis BR; Grill DE; Pruthi RK; Heit JA Eur J Intern Med; 2016 May; 30():77-81. PubMed ID: 26970916 [TBL] [Abstract][Full Text] [Related]
33. Portal vein thrombosis in association with factor V Leiden mutation in a patient with hepatocellular carcinoma. Gürgey A; Büyükpamukcu M; Baskut C; Yalcin B; Gögüş S Med Pediatr Oncol; 1997 Sep; 29(3):224-5. PubMed ID: 9212850 [TBL] [Abstract][Full Text] [Related]
34. An underestimated combination of opposites resulting in enhanced thrombotic tendency. Simioni P; Castoldi E; Lunghi B; Tormene D; Rosing J; Bernardi F Blood; 2005 Oct; 106(7):2363-5. PubMed ID: 15961511 [TBL] [Abstract][Full Text] [Related]
35. The factor V Glu1608Lys mutation is recurrent in familial thrombophilia. Lunghi B; Scanavini D; Castoldi E; Gemmati D; Tognazzo S; Redaelli R; Ghirarduzzi A; Ieran M; Pinotti M; Bernardi F J Thromb Haemost; 2005 Sep; 3(9):2032-8. PubMed ID: 15975136 [TBL] [Abstract][Full Text] [Related]
36. Heterozygous Factor V Leiden deficiency with hepatic thrombosis in a twin pregnancy: a near miss. Disu S; Subair S; Sanusi FA J Obstet Gynaecol; 2003 Sep; 23(5):563-4. PubMed ID: 12963523 [No Abstract] [Full Text] [Related]
37. High prevalence of the FVR506Q mutation causing APC resistance in a region of southern Sweden with a high incidence of venous thrombosis. Zöller B; Norlund L; Leksell H; Nilsson JE; von Schenck H; Rosén U; Jepsson JO; Dahlbäck B Thromb Res; 1996 Sep; 83(6):475-7. PubMed ID: 8885142 [No Abstract] [Full Text] [Related]
38. Impact of factor V Leiden mutation on duration of anticoagulation after a single thromboembolic event. Rintelen C; Pabinger I; Lechner K; Mannhalter C Thromb Haemost; 1997 Feb; 77(2):405. PubMed ID: 9157606 [No Abstract] [Full Text] [Related]
39. Arterial thrombosis associated with heterozygous factor V Leiden disorder, hyperhomocysteinemia, and peripheral arterial disease: importance of synergistic factors. Page C; Rubin LE; Gusberg RJ; Dardik A J Vasc Surg; 2005 Nov; 42(5):1014-8. PubMed ID: 16275464 [TBL] [Abstract][Full Text] [Related]
40. Detection of factor V Leiden from a drop of blood by PCR-SSCP. Corral J; Iniesta JA; González-Conejero R; Vicente V Thromb Haemost; 1996 Nov; 76(5):735-7. PubMed ID: 8950782 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]